Cosmos Holdings Inc. COSM · NASDAQ
$0.26 +3.16% (+$0.01)
Summary
44 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 3.3% a year over 5 years. Over the last 3 years it grew by 9.0% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $24.4M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Wholesale 91%
- Nutraceuticals and Pharmaceuticals 6.5%
- Pharma manufacturing 2.6%
By region
The company reports no revenue by region.
Wholesale brings in 91% of revenue. Pharma manufacturing grew fastest, by 121% a year.
Segments in detail